Cargando…

Identification of Therapeutic Targets in an Emerging Gastrointestinal Pathogen Campylobacter ureolyticus and Possible Intervention through Natural Products

Campylobacter ureolyticus is a Gram-negative, anaerobic, non-spore-forming bacteria that causes gastrointestinal infections. Being the most prevalent cause of bacterial enteritis globally, infection by this bacterium is linked with significant morbidity and mortality in children and immunocompromise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Kanwal, Basharat, Zarrin, Jalal, Khurshid, Mashraqi, Mutaib M., Alzamami, Ahmad, Alshamrani, Saleh, Uddin, Reaz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137744/ https://www.ncbi.nlm.nih.gov/pubmed/35625323 http://dx.doi.org/10.3390/antibiotics11050680

Ejemplares similares

Therapeutic Target Identification and Inhibitor Screening against Riboflavin Synthase of Colorectal Cancer Associated Fusobacterium nucleatum
por: Alturki, Norah A., et al.
Publicado: (2022)

Campylobacter ureolyticus: A portrait of the pathogen
por: O'Donovan, Dylan, et al.
Publicado: (2014)

Chimeric vaccine design against the conserved TonB-dependent receptor-like β-barrel domain from the outer membrane tbpA and hpuB proteins of Kingella kingae ATCC 23330
por: Mashraqi, Mutaib M., et al.
Publicado: (2023)

Mining Autoimmune-Disorder-Linked Molecular-Mimicry Candidates in Clostridioides difficile and Prospects of Mimic-Based Vaccine Design: An In Silico Approach
por: Alshamrani, Saleh, et al.
Publicado: (2023)

Molecular Mimicry Mapping in Streptococcus pneumoniae: Cues for Autoimmune Disorders and Implications for Immune Defense Activation
por: Mashraqi, Mutaib M., et al.
Publicado: (2023)

Genomic Investigation into Strain Heterogeneity and Pathogenic Potential of the Emerging Gastrointestinal Pathogen Campylobacter ureolyticus
por: Bullman, Susan, et al.
Publicado: (2013)

Detection and molecular analysis of Campylobacter ureolyticus in domestic animals
por: Koziel, Monika, et al.
Publicado: (2014)

Molecular-based detection of the gastrointestinal pathogen Campylobacter ureolyticus in unpasteurized milk samples from two cattle farms in Ireland
por: Koziel, Monika, et al.
Publicado: (2012)

Inferring Therapeutic Targets in Candida albicans and Possible Inhibition through Natural Products: A Binding and Physiological Based Pharmacokinetics Snapshot
por: Basharat, Zarrin, et al.
Publicado: (2022)

Species Delineation and Comparative Genomics within the Campylobacter ureolyticus Complex
por: Maki, Joel J., et al.
Publicado: (2023)

Regulation of micro-RNA, epigenetic factor by natural products for the treatment of cancers: Mechanistic insight and translational association
por: Javaid, Anam, et al.
Publicado: (2022)

Complete Genome Sequence of the Campylobacter ureolyticus Clinical Isolate RIGS 9880
por: Miller, William G., et al.
Publicado: (2015)

Reverse vaccinology approach for multi-epitope centered vaccine design against delta variant of the SARS-CoV-2
por: Jalal, Khurshid, et al.
Publicado: (2022)

Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study
por: Alzamami, Ahmad, et al.
Publicado: (2022)

Immunoinformatic-guided designing of multi-epitope vaccine construct against Brucella Suis 1300
por: Jalal, Khurshid, et al.
Publicado: (2022)

Pangenome diversification and resistance gene characterization in Salmonella Typhi prioritized RfaJ as a significant therapeutic marker
por: Khan, Kanwal, et al.
Publicado: (2023)

Pan-Genomics of Escherichia albertii for Antibiotic Resistance Profiling in Different Genome Fractions and Natural Product Mediated Intervention: In Silico Approach
por: Jalal, Khurshid, et al.
Publicado: (2023)

In-Silico Screening and Molecular Dynamics Simulation of Drug Bank Experimental Compounds against SARS-CoV-2
por: Alturki, Norah A., et al.
Publicado: (2022)

Incidence of Campylobacter concisus and C. ureolyticus in traveler’s diarrhea cases and asymptomatic controls in Nepal and Thailand
por: Serichantalergs, Oralak, et al.
Publicado: (2017)

Re-purposing of hepatitis C virus FDA approved direct acting antivirals as potential SARS-CoV-2 protease inhibitors
por: Uddin, Reaz, et al.
Publicado: (2022)

Effect of rifampicin combination-regimens against multi-drug resistant strains in North India
por: Rafeeq, Misbahuddin M, et al.
Publicado: (2022)

Presence of Helicobacter pylori and Campylobacter ureolyticus in the oral cavity of a Northern Thailand population that experiences stomach pain
por: Basic, Amina, et al.
Publicado: (2018)

Comparative Metabolic Pathways Analysis and Subtractive Genomics Profiling to Prioritize Potential Drug Targets Against Streptococcus pneumoniae
por: Khan, Kanwal, et al.
Publicado: (2022)

Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant
por: Khan, Kanwal, et al.
Publicado: (2022)

Draft Genome Sequence of Campylobacter ureolyticus Strain CIT007, the First Whole-Genome Sequence of a Clinical Isolate
por: Lucid, Alan, et al.
Publicado: (2014)

Biocomputational Prediction Approach Targeting FimH by Natural SGLT2 Inhibitors: A Possible Way to Overcome the Uropathogenic Effect of SGLT2 Inhibitor Drugs
por: Mashraqi, Mutaib M., et al.
Publicado: (2021)

Identification of a Novel Therapeutic Target against XDR Salmonella Typhi H58 Using Genomics Driven Approach Followed Up by Natural Products Virtual Screening
por: Jalal, Khurshid, et al.
Publicado: (2021)

Identification of vaccine and drug targets in Shigella dysenteriae sd197 using reverse vaccinology approach
por: Jalal, Khurshid, et al.
Publicado: (2022)

Integrated bioinformatics based subtractive genomics approach to decipher the therapeutic function of hypothetical proteins from Salmonella typhi XDR H-58 strain
por: Khan, Kanwal, et al.
Publicado: (2022)

Proteome based mapping and molecular docking revealed DnaA as a potential drug target against Shigella sonnei
por: Shahid, Farah, et al.
Publicado: (2022)

Pan-Genome Reverse Vaccinology Approach for the Design of Multi-Epitope Vaccine Construct against Escherichia albertii
por: Jalal, Khurshid, et al.
Publicado: (2021)

Identification of Potent Natural Resource Small Molecule Inhibitor to Control Vibrio cholera by Targeting Its Outer Membrane Protein U: An In Silico Approach
por: Rahaman, Abdul, et al.
Publicado: (2021)

Identification of potent compounds against SARs-CoV-2: An in-silico based drug searching against Mpro
por: Hassam, Muhammad, et al.
Publicado: (2022)

Draft Genome Sequence of the Uropathogenic Herbaspirillum frisingense Strain ureolyticus VT-16-41
por: Tetz, Victor, et al.
Publicado: (2017)

Proteogenomic analysis of Serratia marcescens using computational subtractive genomics approach
por: D’Souza, Sharon Elaine, et al.
Publicado: (2023)

Prediction Model of Adverse Effects on Liver Functions of COVID-19 ICU Patients
por: Mashraqi, Aisha, et al.
Publicado: (2022)

Effect of Ducrosia flabellifolia and Savignya parviflora Extracts on Inhibition of Human Colon and Prostate Cancer Cell Lines
por: Alghamdi, Youssef Saeed, et al.
Publicado: (2021)

Subtractive genomics profiling for potential drug targets identification against Moraxella catarrhalis
por: Ashraf, Bilal, et al.
Publicado: (2022)

Development of a Candidate Multi-Epitope Subunit Vaccine against Klebsiella aerogenes: Subtractive Proteomics and Immuno-Informatics Approach
por: Umar, Ahitsham, et al.
Publicado: (2021)

Coinfection of pulmonary tuberculosis with other lower respiratory tract infections: A retrospective cross-sectional study
por: Aldriwesh, Marwh G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vour1c5c24sj0hchnetvs4r9v8